Skip to main content
. 2021 Feb;9(4):330. doi: 10.21037/atm-20-7600

Figure 4.

Figure 4

The role of a metabolism-related gene risk model in different breast cancer cohorts in TCGA dataset. (A,B) The prognostic analysis in TNM stage I–II or TNM stage III–IV patients. (C,D) The prognostic analysis in patients with or without lymphatic invasion. (E,F) The prognostic analysis in T1–T2 or T3–T4 patients. (G,H) The prognostic analysis in PR-negative or PR-positive patients. (I,J) The prognostic analysis in ER-negative or ER-positive patients. (K,L) The prognostic analysis in HER2-negative or HER2-positive patients. TCGA, The Cancer Genome Atlas; T, tumor; N, node (lymph node); M, metastasis; PR, progesterone receptor; ER, estrogen receptor; HER2, human epithelial growth factor receptor 2.